|
|
View Clinical Trial (Medical Research Study)
|
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers - NCT00024635-20892 (Clinical Trial 403559)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy403559.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Bethesda |
|
State:
|
|
MD |
| Zip Code: |
|
20892 |
| Conditions: |
|
Mood Disorder - Anxiety Disorder |
| Purpose: |
|
The purpose of this protocol is to allow for the careful screening of patients and healthy
volunteers for participation in research protocols in the Mood and Anxiety Disorders Program
(MAP) at the National Institute of Mental Health (NIMH) and for the collection of natural
history data. Subjects in this protocol will undergo an evaluation which may include: a
psychiatric interview; a diagnostic interview; rating scales; a medical history; a physical
exam; brain magnetic resonance imaging (MRI); electroencephalography (EEG);
magnetoencephalography (MEG); blood and urine laboratory evaluation; and a request for
medical records. The data collected may also be linked with data from other mood and
anxiety disorder protocols (e.g., brain imaging, DNA, psychophysiology tests, treatment
studies, etc) for the purposes of better understanding the diagnosis, pathophysiology, and
treatment response of patients with mood disorders. Parents of minors will be interviewed.
Upon conclusion of the screening process, subjects will either be offered participation in a
research protocol and will sign the appropriate informed consent, or will be considered not
appropriate for participation in research and will be referred back into the community. The
current protocol thus serves as an entry point for individuals with mood or anxiety
disorders or healthy volunteers to enter NIMH IRB approved MAP protocols....
|
| Study summary: |
|
The purpose of this protocol is to allow for the careful screening of patients and healthy
volunteers for participation in research protocols in the Mood and Anxiety Disorders Program
(MAP) at the National Institute of Mental Health (NIMH) and for the collection of natural
history data. Subjects in this protocol will undergo an evaluation which may include: a
psychiatric interview; a diagnostic interview; rating scales; a medical history; a physical
exam; brain magnetic resonance imaging (MRI); electroencephalography (EEG);
magnetoencephalography (MEG); blood, saliva and urine laboratory evaluation; and a request
for medical records. The data collected may also be linked with data from other mood and
anxiety disorder protocols (e.g., brain imaging, DNA, psychophysiology tests, treatment
studies, etc) for the purposes of better understanding the diagnosis, pathophysiology, and
treatment response of patients with mood disorders. Parents of minors will be interviewed.
Upon conclusion of the screening process, subjects will either be offered participation in a
research protocol and will sign the appropriate informed consent, or will be considered not
appropriate for participation in research and will be referred back into the community. The
current protocol thus serves as an entry point for individuals with mood or anxiety
disorders or healthy volunteers to enter NIMH IRB approved MAP protocols. |
| Criteria: |
|
- INCLUSION CRITERIA:
Subjects must be competent to comprehend the purpose of the screening process and to
provide written informed consent and be willing to participate in NIMH IRB approved
research protocols. Minors will be asked to assent and their parents will sign the
consent form.
Subjects will undergo an evaluation which may include a psychiatric interview, medical
(including Tanner staging for minors), neurological, and laboratory examinations (as
appropriate such as EKG, EEG, renal and liver function tests, serum electrolytes,
urinalysis, HIV, hepatitis A, B, and C, blood levels of psychotropic drugs, pregnancy
testing, and urine drug screen for the presence of psychoactive drugs and drugs of abuse).
EXCLUSION CRITERIA:
Subjects should have no general medical illness that is primary (i.e., appears to be
causing the mood disorder or anxiety disorder).
Current alcohol or substance use or dependence (excluding nicotine) of sufficient
magnitude to require independent, concurrent treatment intervention (e.g., antabuse or
opiate treatment, but not including self-help groups).
Whether the minor lives with both parents or one parent, the parent(s) he/she lives with
must have legal custody. If a parent has shared custody, both parents must consent to
participate in this protocol. |
|
|
|
| Study is available at: |
|
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, MD 20892
United States
Primary Contact:
Brenda Y. Gray
Email: moodresearch@mail.nih.gov
Phone: (877) 646-3644 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 15, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|
|
|
|